BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1.


Journal

Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374

Informations de publication

Date de publication:
03 2021
Historique:
received: 28 08 2020
accepted: 23 12 2020
pubmed: 17 2 2021
medline: 30 4 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

Mutations in the E3 ubiquitin ligase RING domains of BRCA1/BARD1 predispose carriers to breast and ovarian cancers. We present the structure of the BRCA1/BARD1 RING heterodimer with the E2 enzyme UbcH5c bound to its cellular target, the nucleosome, along with biochemical data that explain how the complex selectively ubiquitylates lysines 125, 127 and 129 in the flexible C-terminal tail of H2A in a fully human system. The structure reveals that a novel BARD1-histone interface couples to a repositioning of UbcH5c compared to the structurally similar PRC1 E3 ligase Ring1b/Bmi1 that ubiquitylates H2A Lys119 in nucleosomes. This interface is sensitive to both H3 Lys79 methylation status and mutations found in individuals with cancer. Furthermore, NMR reveals an unexpected mode of E3-mediated substrate regulation through modulation of dynamics in the C-terminal tail of H2A. Our findings provide insight into how E3 ligases preferentially target nearby lysine residues in nucleosomes by a steric occlusion and distancing mechanism.

Identifiants

pubmed: 33589814
doi: 10.1038/s41594-020-00556-4
pii: 10.1038/s41594-020-00556-4
pmc: PMC8007219
mid: NIHMS1657757
doi:

Substances chimiques

BRCA1 Protein 0
BRCA1 protein, human 0
Histones 0
Nucleosomes 0
Tumor Suppressor Proteins 0
UBE2D3 protein, human EC 2.3.2.23
Ubiquitin-Conjugating Enzymes EC 2.3.2.23
BARD1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

268-277

Subventions

Organisme : NIH HHS
ID : S10 OD023476
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007270
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM110430
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM088055
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008268
Pays : United States

Références

Tarsounas, M. & Sung, P. The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication. Nat. Rev. Mol. Cell Biol. 21, 284–299 (2020).
pubmed: 32094664 pmcid: 7204409 doi: 10.1038/s41580-020-0218-z
Densham, R. M. & Morris, J. R. Moving mountains—the BRCA1 promotion of DNA resection. Front. Mol. Biosci. 6, 79 (2019).
pubmed: 31552267 pmcid: 6733915 doi: 10.3389/fmolb.2019.00079
Hashizume, R. et al. The RING heterodimer BRCA1–BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276, 14537–14540 (2001).
pubmed: 11278247 doi: 10.1074/jbc.C000881200
Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C. & Klevit, R. E. Structure of a BRCA1–BARD1 heterodimeric RING–RING complex. Nat. Struct. Biol. 8, 833–837 (2001).
pubmed: 11573085 doi: 10.1038/nsb1001-833
Wu, W. et al. BRCA1 ubiquitinates RPB8 in response to DNA damage. Cancer Res. 67, 951–958 (2007).
pubmed: 17283126 doi: 10.1158/0008-5472.CAN-06-3187
Sato, K. et al. A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation and DNA repair. Curr. Biol. 22, 1659–1666 (2012).
pubmed: 22863316 doi: 10.1016/j.cub.2012.07.034
Vázquez-Arreguín, K. et al. BRCA1 through its E3 ligase activity regulates the transcription factor Oct1 and carbohydrate metabolism. Mol. Cancer Res. 16, 439–452 (2018).
pubmed: 29330289 pmcid: 5835178 doi: 10.1158/1541-7786.MCR-17-0364
Reid, L. J. et al. E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proc. Natl Acad. Sci. USA 105, 20876–20881 (2008).
pubmed: 19088202 pmcid: 2603436 doi: 10.1073/pnas.0811203106
Shakya, R. et al. BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science 334, 525–528 (2011).
pubmed: 22034435 pmcid: 3904783 doi: 10.1126/science.1209909
Drost, R. et al. BRCA1 ring function is essential for tumor suppression but dispensable for therapy resistance. Cancer Cell 20, 797–809 (2011).
pubmed: 22172724 doi: 10.1016/j.ccr.2011.11.014
Densham, R. M. et al. Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection. Nat. Struct. Mol. Biol. 23, 647–655 (2016).
pubmed: 27239795 pmcid: 6522385 doi: 10.1038/nsmb.3236
Densham, R. M. & Morris, J. R. The BRCA1 ubiquitin ligase function sets a new trend for remodelling in DNA repair. Nucleus 8, 116–125 (2017).
pubmed: 28032817 doi: 10.1080/19491034.2016.1267092
Thakar, A., Parvin, J. D. & Zlatanova, J. BRCA1/BARD1 E3 ubiquitin ligase can modify histones H2A and H2B in the nucleosome particle. J. Biomol. Struct. Dyn. 27, 399–405 (2010).
pubmed: 19916563 doi: 10.1080/07391102.2010.10507326
Kalb, R., Mallery, D. L., Larkin, C., Huang, J. T. J. & Hiom, K. BRCA1 is a histone-H2A-specific ubiquitin ligase. Cell Rep. 8, 999–1005 (2014).
pubmed: 25131202 pmcid: 4382519 doi: 10.1016/j.celrep.2014.07.025
Zhu, Q. et al. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477, 179–184 (2011).
pubmed: 21901007 pmcid: 3240576 doi: 10.1038/nature10371
Kim, B.-J. et al. The histone variant MacroH2A1 is a BRCA1 ubiquitin ligase substrate. Cell Rep. 19, 1758–1766 (2017).
pubmed: 28564596 pmcid: 6507409 doi: 10.1016/j.celrep.2017.05.027
Stewart, M. D. et al. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes. Proc. Natl Acad. Sci. USA 115, 1316–1321 (2018).
pubmed: 29367421 pmcid: 5819413 doi: 10.1073/pnas.1715467115
Uckelmann, M. et al. USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A. Nat. Commun. 9, 229 (2018).
pubmed: 29335415 pmcid: 5768779 doi: 10.1038/s41467-017-02653-3
Mattiroli, F. et al. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell 150, 1182–1195 (2012).
pubmed: 22980979 doi: 10.1016/j.cell.2012.08.005
Mattiroli, F., Uckelmann, M., Sahtoe, D. D., van Dijk, W. J. & Sixma, T. K. The nucleosome acidic patch plays a critical role in RNF168-dependent ubiquitination of histone H2A. Nat. Commun. 5, 3291 (2014).
pubmed: 24518117 doi: 10.1038/ncomms4291
Fradet-Turcotte, A. et al. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature 499, 50–54 (2013).
pubmed: 23760478 pmcid: 3955401 doi: 10.1038/nature12318
Wilson, M. D. et al. The structural basis of modified nucleosome recognition by 53BP1. Nature 536, 100–103 (2016).
pubmed: 27462807 doi: 10.1038/nature18951
Wang, H. et al. Role of histone H2A ubiquitination in polycomb silencing. Nature 431, 873–878 (2004).
pubmed: 15386022 doi: 10.1038/nature02985
Cao, R., Tsukada, Y. & Zhang, Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20, 845–854 (2005).
pubmed: 16359901 doi: 10.1016/j.molcel.2005.12.002
Tamburri, S. et al. Histone H2AK119 mono-ubiquitination is essential for polycomb-mediated transcriptional repression. Mol. Cell 77, 840–856 (2020).
pubmed: 31883952 pmcid: 7033561 doi: 10.1016/j.molcel.2019.11.021
Vissers, J. H. A., van Lohuizen, M. & Citterio, E. The emerging role of Polycomb repressors in the response to DNA damage. J. Cell Sci. 125, 3939–3948 (2012).
pubmed: 23104738 doi: 10.1242/jcs.107375
McGinty, R. K., Henrici, R. C. & Tan, S. Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome. Nature 514, 591–596 (2014).
pubmed: 25355358 pmcid: 4215650 doi: 10.1038/nature13890
Horn, V. et al. Structural basis of specific H2A K13/K15 ubiquitination by RNF168. Nat. Commun. 10, 1751 (2019).
pubmed: 30988309 pmcid: 6465349 doi: 10.1038/s41467-019-09756-z
Brzovic, P. S. et al. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl Acad. Sci. USA 100, 5646–5651 (2003).
pubmed: 12732733 pmcid: 156255 doi: 10.1073/pnas.0836054100
Anderson, C. J. et al. Structural basis for recognition of ubiquitylated nucleosome by Dot1L methyltransferase. Cell Rep. 26, 1681–1690 (2019).
pubmed: 30759380 pmcid: 6392056 doi: 10.1016/j.celrep.2019.01.058
Valencia-Sánchez, M. I. et al. Structural basis of Dot1L stimulation by histone H2B lysine 120 ubiquitination. Mol. Cell 74, 1010–1019 (2019).
pubmed: 30981630 pmcid: 7009778 doi: 10.1016/j.molcel.2019.03.029
Song, Y. et al. High-resolution comparative modeling with RosettaCM. Structure 21, 1735–1742 (2013).
pubmed: 24035711 doi: 10.1016/j.str.2013.08.005
Yang, J. et al. Improved protein structure prediction using predicted interresidue orientations. Proc. Natl Acad. Sci. USA 117, 1496–1503 (2020).
pubmed: 31896580 pmcid: 6983395 doi: 10.1073/pnas.1914677117
McGinty, R. K. & Tan, S. Recognition of the nucleosome by chromatin factors and enzymes. Curr. Opin. Struct. Biol. 37, 54–61 (2016).
pubmed: 26764865 pmcid: 4834262 doi: 10.1016/j.sbi.2015.11.014
Taherbhoy, A. M., Huang, O. W. & Cochran, A. G. BMI1–RING1B is an autoinhibited RING E3 ubiquitin ligase. Nat. Commun. 6, 7621 (2015).
pubmed: 26151332 doi: 10.1038/ncomms8621
Wood, K., Tellier, M. & Murphy, S. DOT1L and H3K79 methylation in transcription and genomic stability. Biomolecules 8, 11 (2018).
pmcid: 5871980 doi: 10.3390/biom8010011
Nguyen, A. T. & Zhang, Y. The diverse functions of Dot1 and H3K79 methylation. Genes Dev. 25, 1345–1358 (2011).
pubmed: 21724828 pmcid: 3134078 doi: 10.1101/gad.2057811
Huyen, Y. et al. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432, 406–411 (2004).
pubmed: 15525939 doi: 10.1038/nature03114
Wysocki, R. et al. Role of Dot1-dependent histone H3 methylation in G1 and S phase DNA damage checkpoint functions of Rad9. Mol. Cell. Biol. 25, 8430–8443 (2005).
pubmed: 16166626 pmcid: 1265753 doi: 10.1128/MCB.25.19.8430-8443.2005
Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941–D947 (2019).
pubmed: 30371878 doi: 10.1093/nar/gky1015
Shah, S., Verma, T., Rashid, M., Gadewal, N. & Gupta, S. Histone H2A isoforms: potential implications in epigenome plasticity and diseases in eukaryotes. J. Biosci. 45, 4 (2020).
pubmed: 31965982 doi: 10.1007/s12038-019-9985-0
Nakamura, K. et al. H4K20me0 recognition by BRCA1–BARD1 directs homologous recombination to sister chromatids. Nat. Cell Biol. 21, 311–318 (2019).
pubmed: 30804502 pmcid: 6420097 doi: 10.1038/s41556-019-0282-9
Becker, J. R. et al. BARD1 links histone H2A Lysine-15 ubiquitination to initiation of BRCA1-dependent homologous recombination. Preprint at bioRxiv https://doi.org/10.1101/2020.06.01.127951 (2020).
Masuda, T., Xu, X., Dimitriadis, E. K., Lahusen, T. & Deng, C.-X. ‘DNA binding region’ of BRCA1 affects genetic stability through modulating the intra-S-phase checkpoint. Int. J. Biol. Sci. 12, 133–143 (2016).
pubmed: 26884712 pmcid: 4737671 doi: 10.7150/ijbs.14242
Zhao, W. et al. BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing. Nature 550, 360–365 (2017).
pubmed: 28976962 pmcid: 5800781 doi: 10.1038/nature24060
Streich, F. C. Jr & Lima, C. D. Capturing a substrate in an activated RING E3/E2–SUMO complex. Nature 536, 304–308 (2016).
pubmed: 27509863 pmcid: 5019495 doi: 10.1038/nature19071
Scott, D. C. et al. Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8. Cell 157, 1671–1684 (2014).
pubmed: 24949976 pmcid: 4247792 doi: 10.1016/j.cell.2014.04.037
Brown, N. G. et al. RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex. Proc. Natl Acad. Sci. USA 112, 5272–5279 (2015).
pubmed: 25825779 pmcid: 4418899 doi: 10.1073/pnas.1504161112
Eddins, M. J., Carlile, C. M., Gomez, K. M., Pickart, C. M. & Wolberger, C. Mms2–Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nat. Struct. Mol. Biol. 13, 915–920 (2006).
pubmed: 16980971 doi: 10.1038/nsmb1148
Pruneda, J. N. et al. Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. Mol. Cell 47, 933–942 (2012).
pubmed: 22885007 pmcid: 3462262 doi: 10.1016/j.molcel.2012.07.001
Paull, T. T. et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886–895 (2000).
pubmed: 10959836 doi: 10.1016/S0960-9822(00)00610-2
Cooper, S. et al. Jarid2 binds mono-ubiquitylated H2A lysine 119 to mediate crosstalk between Polycomb complexes PRC1 and PRC2. Nat. Commun. 7, 13661 (2016).
pubmed: 27892467 pmcid: 5133711 doi: 10.1038/ncomms13661
Savage, K. I. & Harkin, D. P. BRCA1, a ‘complex’ protein involved in the maintenance of genomic stability. FEBS J. 282, 630–646 (2015).
pubmed: 25400280 doi: 10.1111/febs.13150
Belotserkovskaya, R. et al. PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1. Nat. Commun. 11, 819 (2020).
pubmed: 32041954 pmcid: 7010753 doi: 10.1038/s41467-020-14563-y
Carrion-Vazquez, M., Marszalek, P. E., Oberhauser, A. F. & Fernandez, J. M. Atomic force microscopy captures length phenotypes in single proteins. Proc. Natl Acad. Sci. USA 96, 11288–11292 (1999).
pubmed: 10500169 pmcid: 18026 doi: 10.1073/pnas.96.20.11288
Aiyar, A., Xiang, Y. & Leis, J. Site-directed mutagenesis using overlap extension PCR. Methods Mol. Biol. 57, 177–191 (1996).
pubmed: 8850005
Christensen, D. E., Brzovic, P. S. & Klevit, R. E. E2–BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat. Struct. Mol. Biol. 14, 941–948 (2007).
pubmed: 17873885 doi: 10.1038/nsmb1295
Lazar, G. A., Desjarlais, J. R. & Handel, T. M. De novo design of the hydrophobic core of ubiquitin. Protein Sci. 6, 1167–1178 (1997).
pubmed: 9194177 pmcid: 2143711 doi: 10.1002/pro.5560060605
Lee, Y.-T., Gibbons, G., Lee, S. Y., Nikolovska-Coleska, Z. & Dou, Y. One-pot refolding of core histones from bacterial inclusion bodies allows rapid reconstitution of histone octamer. Protein Expr. Purif. 110, 89–94 (2015).
pubmed: 25687285 pmcid: 4403241 doi: 10.1016/j.pep.2015.02.007
Luger, K., Rechsteiner, T. J. & Richmond, T. J. Preparation of nucleosome core particle from recombinant histones. Methods Enzymol. 304, 3–19 (1999).
pubmed: 10372352 doi: 10.1016/S0076-6879(99)04003-3
Dhall, A. et al. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. J. Biol. Chem. 289, 33827–33837 (2014).
pubmed: 25294883 pmcid: 4256319 doi: 10.1074/jbc.M114.591644
Simon, M. D. et al. The site-specific installation of methyl-lysine analogs into recombinant histones. Cell 128, 1003–1012 (2007).
pubmed: 17350582 pmcid: 2932701 doi: 10.1016/j.cell.2006.12.041
Dyer, P. N. et al. Reconstitution of nucleosome core particles from recombinant histones and DNA. Methods Enzymol. 375, 23–44 (2004).
pubmed: 14870657 doi: 10.1016/S0076-6879(03)75002-2
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084
Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
pubmed: 28710774 doi: 10.1002/pro.3235
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
pubmed: 2231712 doi: 10.1016/S0022-2836(05)80360-2
Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
pubmed: 8520220 doi: 10.1007/BF00197809
Johnson, B. A. Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 278, 313–352 (2004).
pubmed: 15318002
Morrison, E. A., Bowerman, S., Sylvers, K. L., Wereszczynski, J. & Musselman, C. A. The conformation of the histone H3 tail inhibits association of the BPTF PHD finger with the nucleosome. Elife 7, e31481 (2018).
pubmed: 29648537 pmcid: 5953545 doi: 10.7554/eLife.31481

Auteurs

Samuel R Witus (SR)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Anika L Burrell (AL)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Daniel P Farrell (DP)

Department of Biochemistry, University of Washington, Seattle, WA, USA.
Institute for Protein Design, University of Washington, Seattle, WA, USA.

Jianming Kang (J)

Department of Biochemistry, University of Washington, Seattle, WA, USA.
Department of Chemistry, University of Washington, Seattle, WA, USA.

Meiling Wang (M)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.

Jesse M Hansen (JM)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Alex Pravat (A)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Lisa M Tuttle (LM)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Mikaela D Stewart (MD)

Department of Biochemistry, University of Washington, Seattle, WA, USA.
Department of Biology, Texas Christian University, Fort Worth, TX, USA.

Peter S Brzovic (PS)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Champak Chatterjee (C)

Department of Chemistry, University of Washington, Seattle, WA, USA.

Weixing Zhao (W)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.

Frank DiMaio (F)

Department of Biochemistry, University of Washington, Seattle, WA, USA.
Institute for Protein Design, University of Washington, Seattle, WA, USA.

Justin M Kollman (JM)

Department of Biochemistry, University of Washington, Seattle, WA, USA.

Rachel E Klevit (RE)

Department of Biochemistry, University of Washington, Seattle, WA, USA. klevit@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH